The Patent Finder

Heidelberg Pharma GmbH

Also on record
Records under this name other than the patents Heidelberg Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Heidelberg Pharma GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,399,681Amatoxin-conjugates with improved linkers
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,676,702Methods for synthesizing amatoxin building block and amatoxins
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,419,965Nucleotide lipid ester derivatives
Lapsed on the fee record
Ended Sep 2, 2012 · USPTO record
Lapsed on the fee recordEnded Sep 2, 2012USPTO record
US 7,378,401Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases
Lapsed on the fee record
Ended May 27, 2012 · USPTO record
Lapsed on the fee recordEnded May 27, 2012USPTO record
US 6,025,343Lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs
Lapsed on the fee record
Ended Feb 15, 2012 · USPTO record
Lapsed on the fee recordEnded Feb 15, 2012USPTO record
US 6,521,262Solid instant-release forms of administration and process for producing the same
Lapsed on the fee record
Ended Feb 18, 2011 · USPTO record
Lapsed on the fee recordEnded Feb 18, 2011USPTO record
US 7,176,011Lipid cleavage enzyme
Lapsed on the fee record
Ended Feb 13, 2011 · USPTO record
Lapsed on the fee recordEnded Feb 13, 2011USPTO record
US 6,177,469Lipid alcohols as new immunosuppressive and antiviral drugs
Lapsed on the fee record
Ended Jan 23, 2009 · USPTO record
Lapsed on the fee recordEnded Jan 23, 2009USPTO record
US 6,136,797Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
Lapsed on the fee record
Ended Oct 24, 2008 · USPTO record
Lapsed on the fee recordEnded Oct 24, 2008USPTO record
US 6,080,734Liponucleotides of seco-nucleosides, their production as well as their use as antiviral pharmaceutical agents
Lapsed on the fee record
Ended Jun 27, 2008 · USPTO record
Lapsed on the fee recordEnded Jun 27, 2008USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited